AMERICAN INTERNATIONAL GROUP, INC. - AMPIO PHARMACEUTICALS INC ownership

AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 132 filers reported holding AMPIO PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.

Quarter-by-quarter ownership
AMERICAN INTERNATIONAL GROUP, INC. ownership history of AMPIO PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$45,000
-23.7%
96,737
-6.6%
0.00%
Q4 2021$59,000
-66.7%
103,545
-2.9%
0.00%
-100.0%
Q3 2021$177,000
-0.6%
106,644
+0.1%
0.00%0.0%
Q2 2021$178,000
+408.6%
106,581
+70.7%
0.00%
Q1 2019$35,000
+40.0%
62,427
-3.1%
0.00%
Q4 2018$25,000
-24.2%
64,450
-0.8%
0.00%
Q3 2018$33,000
-71.1%
64,947
+25.7%
0.00%
Q2 2018$114,000
+418.2%
51,671
+90.1%
0.00%
Q1 2017$22,000
-4.3%
27,188
+7.6%
0.00%
Q4 2016$23,000
-99.9%
25,263
-0.3%
0.00%
Q3 2016$18,749,000
-42.5%
25,329
+0.2%
0.00%
Q2 2016$32,625,000
-45.6%
25,291
-5.3%
0.00%
Q1 2016$60,000,000
-35.5%
26,7000.0%0.00%
Q4 2015$93,000,000
+120679.2%
26,7000.0%0.00%
Q3 2015$77,000
-99.9%
26,700
+3.9%
0.00%
Q2 2015$60,909,000
-86.6%
25,700
-57.6%
0.00%
-100.0%
Q1 2015$456,025,000
+110.8%
60,561
-4.0%
0.00%
+100.0%
Q4 2014$216,300,000
-4.4%
63,061
-1.6%
0.00%0.0%
Q3 2014$226,199,000
-50.1%
64,079
+18.1%
0.00%
-50.0%
Q2 2014$453,029,000
+57.3%
54,255
+19.6%
0.00%
+100.0%
Q1 2014$287,973,000
-1.1%
45,350
+11.0%
0.00%0.0%
Q4 2013$291,203,000
+0.2%
40,842
+5.4%
0.00%
-50.0%
Q3 2013$290,490,000
+32.9%
38,732
+2.2%
0.00%
+100.0%
Q2 2013$218,648,00037,8940.00%
Other shareholders
AMPIO PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Empery Asset Management, LP 4,262,409$2,430,0005.07%
CVI Holdings, LLC 5,171,896$2,948,0000.20%
PRIVATE CAPITAL MANAGEMENT LLC 937,237$534,0000.18%
CVA Family Office, LLC 1,137,920$649,0000.16%
ACT CAPITAL MANAGEMENT, LLC 291,500$166,0000.12%
Cypress Capital Management LLC (WY) 196,775$112,0000.09%
Willis Investment Counsel 2,181,840$1,244,0000.06%
NTB Financial Corp 146,100$83,0000.06%
Helen Stephens Group, LLC 117,222$67,0000.05%
SRS Capital Advisors, Inc. 629,172$359,0000.05%
View complete list of AMPIO PHARMACEUTICALS INC shareholders